IPAMORELIN 5MG

IPAMORELIN 5MG | SELECTIVE GHS-R AGONIST

Ipamorelin is a potent, second-generation pentapeptide that acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). This 5mg formulation is precision-engineered for research focused on isolated endogenous growth hormone (GH) release, offering high-fidelity stimulation with minimal off-target effects.

Key Research Mechanisms

• Targeted GH Pulsatility: Research indicates that Ipamorelin mimics the action of ghrelin to trigger a GH pulse from the anterior pituitary gland, making it a primary subject for studies on natural growth hormone cycles.

• Hormonal Selectivity: Unlike earlier secretagogues, Ipamorelin is highly regarded in research for its lack of impact on ACTH, cortisol, or prolactin levels, allowing for the study of GH in isolation.

• Cellular & Muscle Homeostasis: Investigations center on its role in promoting nitrogen retention and protein synthesis, critical for research involving muscle wasting and lean tissue preservation.

• Regenerative Potential: It is extensively used in studies related to bone mineral density (BMD) and the acceleration of systemic recovery following physiological stress.

Product Specifications

• Concentration: 5mg

• Form: Lyophilized Powder

• Purity: >99% (HPLC Verified)

• Molecular Formula: $C_{38}H_{49}N_{9}O_{5}$

• Storage: Store at -20°C for long-term stability. Maintain in a dry, dark environment. Once reconstituted, store at 2°C–8°C for up to 21 days to ensure peptide stability.

The LNGVIX Advantage

The 5mg Ipamorelin is synthesized using high-purity solid-phase techniques to ensure a consistent molecular structure, providing researchers with reliable and reproducible data in endocrinology and metabolic modeling.

LABORATORY PRECAUTION: This product is intended for laboratory research use only. It is not for human consumption, diagnostic, or therapeutic use. All research protocols must be executed by qualified laboratory professionals.